CH
BMY icon

Canton Hathaway’s Bristol-Myers Squibb BMY Stock Holding History

Canton Hathaway’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$90.2K Hold
1,445
– – 0.02% 165
2026
Q2 		$83.3K Sell
1,445
-1,950
-57% -$112K 0.02% 168
2026
Q1 		$206K Buy
3,395
+125
+4% +$7.29K 0.04% 128
2025
Q4 		$176K Buy
3,270
+1,950
+148% +$93.8K 0.03% 139
2025
Q3 		$60K Hold
1,320
– – 0.01% 195
2025
Q2 		$61K Buy
1,320
+50
+4% +$2.45K 0.01% 186
2025
Q1 		$77K Buy
1,270
+275
+28% +$16K 0.02% 175
2024
Q4 		$56K Buy
995
+300
+43% +$16.8K 0.01% 155
2024
Q3 		$36K Hold
695
– – 0.01% 187
2024
Q2 		$29K Hold
695
– – 0.01% 202
2024
Q1 		$38K Hold
695
– – 0.01% 176
2023
Q4 		$36K Hold
695
– – 0.01% 181
2023
Q3 		$40K Hold
695
– – 0.01% 167
2023
Q2 		$44K Hold
695
– – 0.01% 166
2023
Q1 		$48K Hold
695
– – 0.02% 157
2022
Q4 		$50K Hold
695
– – 0.02% 162
2022
Q3 		$49K Sell
695
-500
-42% -$36.3K 0.02% 153
2022
Q2 		$92K Hold
1,195
– – 0.03% 127
2022
Q1 		$87K Hold
1,195
– – 0.02% 136
2021
Q4 		$75K Sell
1,195
-25,343
-95% -$1.49M 0.02% 157
2021
Q3 		$1.57M Sell
26,538
-4,505
-15% -$297K 0.45% 43
2021
Q2 		$2.07M Sell
31,043
-839
-3% -$54.7K 0.61% 33
2021
Q1 		$2.01M Buy
31,882
+6,582
+26% +$410K 0.64% 29
2020
Q4 		$1.57M Buy
25,300
+9,110
+56% +$560K 0.53% 37
2020
Q3 		$976K Buy
16,190
+10,290
+174% +$619K 0.4% 36
2020
Q2 		$347K Sell
5,900
-940
-14% -$56.2K 0.23% 52
2020
Q1 		$381K Buy
6,840
+940
+16% +$57.5K 0.27% 40
2019
Q4 		$379K Sell
5,900
-870
-13% -$49.8K 0.19% 61
2019
Q3 		$343K Buy
6,770
+6,270
+1,254% +$295K 0.19% 61
2019
Q2 		$23K Hold
500
– – 0.01% 171
2019
Q1 		$23K Hold
500
– – 0.01% 170
2018
Q4 		$26K Hold
500
– – 0.02% 130
2018
Q3 		$31K Buy
+500
New +$29.7K 0.02% 117

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Canton Hathaway's BMY Position: Q3 2026 in Review

Canton Hathaway held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 1,445 shares worth $90.2K. The position accounts for 0.02% of the portfolio, ranked #165.

Canton Hathaway first reported a position in BMY in Q3 2018 and has held it in 33 quarters since. The position peaked at $2.07M in Q2 2021. 865 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Canton Hathaway held 1,445 shares of Bristol-Myers Squibb worth $90.2K as of Q3 2026.
  • Canton Hathaway left its Bristol-Myers Squibb share count unchanged in Q3 2026.
  • Bristol-Myers Squibb made up 0.02% of Canton Hathaway's portfolio in Q3 2026, its #165 holding.
  • Canton Hathaway first reported a position in Bristol-Myers Squibb in Q3 2018 and has held it in 33 quarters since.
  • Canton Hathaway's Bristol-Myers Squibb position peaked at $2.07M in Q2 2021.
  • 865 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Canton Hathaway's 13F filing for Q3 2026, filed 23 Oct 2026.